Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Martin P. Rabe
Observed names:
Martin Rabe,
Rabe, Martin
Observed institutions:
Paderborn University,
Sirim Berhad,
Fraunhofer Institute for Mechatronic Systems Design,
Fraunhofer Institute for Production Technology IPT,
Eisai (United States),
Pusat Latihan Teknologi Tinggi (ADTEC) Shah Alam,
Tun Hussein Onn University of Malaysia
show all 7
OpenAlex ID:
A5103998068
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
2021
·
Chad J. Swanson
, Yong Zhang
, et al.
·
Alzheimer s Research & Therapy
·
847
PDF
ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
2016
·
Jinping Wang
, Veronika Logovinsky
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
160
PDF
Building blocks for planning and implementation of smart services based on existing products
2018
·
Tobias Mittag
, Martin Rabe
, et al.
·
Procedia CIRP
·
32
PDF
AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial)
2020
·
Paul S. Aisen
, Jin Zhou
, et al.
·
Alzheimer s & Dementia
·
24
PDF
Correction: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
2022
·
Chad J. Swanson
, Yong Zhang
, et al.
·
Alzheimer s Research & Therapy
·
19
PDF
Framework for the agile development of innovative Product-Service-Systems for existing physical rehabilitation systems
2018
·
Laban Asmar
, Martin Rabe
, et al.
·
Procedia Manufacturing
·
14
PDF
Smart Services – Konzept einer neuen Marktleistung
2018
·
Maximillian Frank
, Christian Koldewey
, et al.
·
Zeitschrift für wirtschaftlichen Fabrikbetrieb
·
13
Venture Client Model: A systematic Literature Review
2023
·
Lennard Haarmann
, Fabian Machon
, et al.
·
European Conference on Innovation and Entrepreneurship
·
10
PDF
Persistence Of BAN2401-Mediated Amyloid Reductions Post-treatment: A Preliminary Comparison of Amyloid Status Between the Core Phase of BAN2401-G000-201 and Baseline of the Open-Label Extension Phase in Subjects with Early Alzheimer’s Disease (1330)
2020
·
Chad J. Swanson
, Yong Zhang
, et al.
·
Neurology
·
10
Data-Driven Product Management: A Practitioner-Driven Research Agenda
2023
·
Khoren Grigoryan
, Timm Fichtler
, et al.
·
Procedia CIRP
·
8
Smart Factory Reference Model for Training on Industry 4.0
2019
·
Ubaidullah Mohammad
, Cheng Yee Low
, et al.
·
Journal of Mechanical Engineering
·
7
PDF
Planning of Smart Services Based on a Reference Architecture
2018
·
Martin Rabe
, Laban Asmar
, et al.
·
Proceedings of the ... International Design Conference/Design ...
·
6
PDF
Lecanemab, an anti-Aβ protofibril antibody: Updated data from a randomized, double-blind phase 2B proof of concept clinical trial and open-label extension in early Alzheimer's disease
2021
·
Chad Swanson
, Shobha Dhadda
, et al.
·
Journal of the Neurological Sciences
·
4
Data-Driven Model for Upper Limb Spasticity Detection
2021
·
Jingye Yee
, Cheng Yee Low
, et al.
·
International Journal of Integrated Engineering
·
4
PDF
Dt‐01‐01: Ban2401 in Early Alzheimer's Disease: Neurodegeneration Biomarker Analysis From a Randomized Phase 2 Study
2019
·
Jose Luis Molinuevo
, Akihiko Koyama
, et al.
·
Alzheimer s & Dementia
·
3
Venture Clienting in Corporate Practice: What type of Established Companies are Using the Venture Client Model?
2024
·
Lennard Haarmann
, Johannes J. Jobelius
, et al.
·
European Conference on Innovation and Entrepreneurship
·
2
PDF
Baseline characteristics for CLARITY AD: A phase 3 placebo‐controlled, double‐blind, parallel‐group, 18‐month study evaluating lecanemab (ban2401) in early Alzheimer's disease
2021
·
Shau Yu Lynch
, Michael C Irizarry
, et al.
·
Alzheimer s & Dementia
·
2
PDF
Holistic Concept for the Implementation of Smart Parking in Small and Medium-Sized Cities
2021
·
Kornelia Schuba
, Magdalena Forster
, et al.
·
IEEE European Technology and Engineering Management Summit (E-TEMS)
·
2
BAN2401 In Early Alzheimer's Disease: A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With An Open-Label Extension Phase To Confirm Safety And Efficacy (1567)
2020
·
Shau Yu Lynch
, Michael Irizarry
, et al.
·
Neurology
·
2
Data Science Platform for Smart Diagnosis of Upper Limb Spasticity
2020
·
Jingye Yee
, Cheng Yee Low
, et al.
·
Procedia Manufacturing
·
2
PDF
Systematic Development of Smart Factory using CONSENS
2018
·
Ubaidullah Mohammad
, Cheng Yee Low
, et al.
·
Procedia Manufacturing
·
2
PDF
Potential of Using Model-based Systems Engineering to Improve the Development Process of Engineering-to-order Products in the Field of Machinery and Plant Engineering
2015
·
Martin Rabe
, Harald Anacker
, et al.
·
Jurnal Teknologi
·
2
Brain MRI signatures across sex and CSF Alzheimer’s disease biomarkers
2025
·
You Cheng
, Yingnan He
, et al.
·
Brain Communications
·
1
PDF
Trial in Progress: An Open-Label, Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104 in Complement Inhibitor-Naïve Subjects with Paroxysmal Nocturnal Hemoglobinuria
2022
·
Fengkui Zhang
, Bing Han
, et al.
·
Blood
·
1
SYNERGY-1: A Phase 1, First-in-Human, Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics Study of KP104 in Escalating Single and Multiple Doses
2022
·
Paul Wabnitz
, Xiang Gao
, et al.
·
Journal of the American Society of Nephrology
·
1
Show more works
View as search
Works count:
51
Citation count:
1,184
H-index:
9
I10-index:
9
Year
Topic
Type